首页 › 基金 › Seven Fleet Capital Management LP › SGMT
Seven Fleet Capital Management LP 对 SGMT 的持仓历史
SAGIMET BIOSCIENCES INC · 医疗保健
Seven Fleet Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 SGMT(SAGIMET BIOSCIENCES INC)429,113 股,市值约 US$4.2M,约占其申报组合的 0.83%,在其申报持仓中市值排名第 20 位。 Seven Fleet Capital Management LP 最近 2 个申报季度中有 2 个季度披露了 SGMT 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Seven Fleet Capital Management LP 对 SGMT 的持仓演变
Seven Fleet Capital Management LP 于 Q2 2026 首次披露 SGMT 持仓:403,545 股(约 US$3.1M)。 该持仓在 Q3 2026 达到峰值 429,113 股,市值约 US$4.2M。 在 2 次申报中,Seven Fleet Capital Management LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 429,113 股、市值约 US$4.2M,环比增持 25,568 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 403.55K | $3.12M | 新进 |
| Q3 2026 | 429.11K | $4.24M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SGMT 与 13F 数据
SGMT(SAGIMET BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 SGMT,申报仓位最大的包括:SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), BVF INC/IL (US$34.6M), Caligan Partners LP (US$27.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SGMT 的基金
- SILVERARC CAPITAL MANAGEMENT, LLC 3.75M 股 · $37.01M · Q3 2026
- BVF INC/IL 3.50M 股 · $34.58M · Q3 2026
- Caligan Partners LP 2.79M 股 · $27.61M · Q3 2026
- Commodore Capital LP 2.76M 股 · $27.25M · Q3 2026
- Affinity Asset Advisors, LLC 2.53M 股 · $24.97M · Q3 2026
- Saturn V Capital Management LP 2.00M 股 · $19.79M · Q3 2026
- GREAT POINT PARTNERS LLC 1.96M 股 · $19.38M · Q3 2026
- Spruce Street Capital LP 1.40M 股 · $13.83M · Q3 2026
- Atom Investors LP 725.92K 股 · $7.17M · Q3 2026
- Jones Hill Capital LP 502.59K 股 · $4.97M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 423.01K 股 · $4.18M · Q3 2026
- Palo Alto Investors LP 250.00K 股 · $2.47M · Q3 2026
更多关于 Seven Fleet Capital Management LP
常见问题
How long has Seven Fleet Capital Management LP held SGMT?
Seven Fleet Capital Management LP has disclosed SGMT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Seven Fleet Capital Management LP's current position in SGMT?
As of Q3 2026, Seven Fleet Capital Management LP holds 429.11K shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $4.24M, representing 0.83% of its reported portfolio and ranking #20.
Has Seven Fleet Capital Management LP been buying or selling SGMT?
In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP increased its position in SGMT. The position peaked in Q3 2026 at 429.11K shares.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.